BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26384652)

  • 1. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
    Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
    Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
    Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
    Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M; Lecca D; Abbracchio MP
    Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATPergic signalling during seizures and epilepsy.
    Engel T; Alves M; Sheedy C; Henshall DC
    Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine and pyrimidine receptors.
    Burnstock G
    Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2 receptor signaling in neurons and glial cells of the central nervous system.
    Köles L; Leichsenring A; Rubini P; Illes P
    Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signaling in Alzheimer's disease.
    Erb L; Woods LT; Khalafalla MG; Weisman GA
    Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic receptors in psychiatric disorders.
    Krügel U
    Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic Regulation of Neutrophil Function.
    Wang X; Chen D
    Front Immunol; 2018; 9():399. PubMed ID: 29545806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine and ATP receptors in the brain.
    Burnstock G; Fredholm BB; Verkhratsky A
    Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2 receptor-mediated signaling in the physiological and pathological brain: From development to aging and disease.
    Mut-Arbona P; Sperlágh B
    Neuropharmacology; 2023 Aug; 233():109541. PubMed ID: 37062423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purines and sensory nerves.
    Burnstock G
    Handb Exp Pharmacol; 2009; (194):333-92. PubMed ID: 19655112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.